Company Filing History:
Years Active: 2006
Title: Helene Debat: Innovator in Catalytic Antibody Modulation
Introduction
Helene Debat is a notable inventor based in Sainte Dode, France. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that modulate the activity of catalytic antibodies. Her innovative work has the potential to impact therapeutic treatments for various pathologies.
Latest Patents
Helene Debat holds 1 patent for her invention titled "Compounds capable of modulating the activity and stimulating the production of a catalytic antibody." This invention focuses on novel compounds that can enhance the activity of antibodies with specific affinities for catalytic sites. Importantly, these compounds are designed to be non-immunogenic, making them suitable for therapeutic applications. They can be utilized in the treatment or prevention of conditions related to enzymatic deficiencies and can stimulate the in vivo hydrolysis of potentially toxic substances.
Career Highlights
Helene Debat is currently associated with Gradient Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on practical applications of her discoveries in the medical field.
Collaborations
Helene collaborates with esteemed colleagues, including Alain Friboulet and Berangere Avalle-Bihan. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in biochemistry.
Conclusion
Helene Debat's contributions to the field of catalytic antibody modulation exemplify the impact of innovative thinking in biochemistry. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.